Cargando…
Posterior Reversible Encephalopathy Syndrome After Self-Medication With an Oral Decongestant: A Case Report
INTRODUCTION: Posterior reversible encephalopathy syndrome (PRES) is a rare neurological disorder caused by the dysregulation of cerebral perfusion. CASE PRESENTATION: We report on a 18-year-old female patient with a history of end-stage renal disease and thrice weekly hemodialysis. She was admitted...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935013/ https://www.ncbi.nlm.nih.gov/pubmed/35321464 http://dx.doi.org/10.3389/fmed.2022.837324 |
_version_ | 1784671955606044672 |
---|---|
author | Zerbib, Yoann Gibert, Louis Bennis, Youssef Masmoudi, Kamel Maizel, Julien Brault, Clément |
author_facet | Zerbib, Yoann Gibert, Louis Bennis, Youssef Masmoudi, Kamel Maizel, Julien Brault, Clément |
author_sort | Zerbib, Yoann |
collection | PubMed |
description | INTRODUCTION: Posterior reversible encephalopathy syndrome (PRES) is a rare neurological disorder caused by the dysregulation of cerebral perfusion. CASE PRESENTATION: We report on a 18-year-old female patient with a history of end-stage renal disease and thrice weekly hemodialysis. She was admitted to the emergency department with mental confusion, blurred vision, headaches, and vomiting, following self-medication with an oral decongestant containing pseudoephedrine. We observed hypointense lesions with T1-weighted MRI and hyperintense areas with T2-weighted and fluid-attenuated inversion recovery MRI sequences. The lack of diffusion restriction was consistent with a diagnosis of PRES. A concomitant Enterobacter cloacae hemodialysis catheter-bloodstream infection was also diagnosed. We hypothesize that both sepsis and inappropriate self-medication with oral pseudoephedrine contributed to hypertension, endothelial dysfunction, and vasogenic edema. The patient received intensive care and made a full recovery. DISCUSSION: PRES is a life-threatening condition that requires intensive care. Identification of the etiology is the keystone of medical care. Inappropriate self-medication with an oral decongestant might trigger PRES - highlighting the importance of patient education. |
format | Online Article Text |
id | pubmed-8935013 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-89350132022-03-22 Posterior Reversible Encephalopathy Syndrome After Self-Medication With an Oral Decongestant: A Case Report Zerbib, Yoann Gibert, Louis Bennis, Youssef Masmoudi, Kamel Maizel, Julien Brault, Clément Front Med (Lausanne) Medicine INTRODUCTION: Posterior reversible encephalopathy syndrome (PRES) is a rare neurological disorder caused by the dysregulation of cerebral perfusion. CASE PRESENTATION: We report on a 18-year-old female patient with a history of end-stage renal disease and thrice weekly hemodialysis. She was admitted to the emergency department with mental confusion, blurred vision, headaches, and vomiting, following self-medication with an oral decongestant containing pseudoephedrine. We observed hypointense lesions with T1-weighted MRI and hyperintense areas with T2-weighted and fluid-attenuated inversion recovery MRI sequences. The lack of diffusion restriction was consistent with a diagnosis of PRES. A concomitant Enterobacter cloacae hemodialysis catheter-bloodstream infection was also diagnosed. We hypothesize that both sepsis and inappropriate self-medication with oral pseudoephedrine contributed to hypertension, endothelial dysfunction, and vasogenic edema. The patient received intensive care and made a full recovery. DISCUSSION: PRES is a life-threatening condition that requires intensive care. Identification of the etiology is the keystone of medical care. Inappropriate self-medication with an oral decongestant might trigger PRES - highlighting the importance of patient education. Frontiers Media S.A. 2022-03-07 /pmc/articles/PMC8935013/ /pubmed/35321464 http://dx.doi.org/10.3389/fmed.2022.837324 Text en Copyright © 2022 Zerbib, Gibert, Bennis, Masmoudi, Maizel and Brault. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Medicine Zerbib, Yoann Gibert, Louis Bennis, Youssef Masmoudi, Kamel Maizel, Julien Brault, Clément Posterior Reversible Encephalopathy Syndrome After Self-Medication With an Oral Decongestant: A Case Report |
title | Posterior Reversible Encephalopathy Syndrome After Self-Medication With an Oral Decongestant: A Case Report |
title_full | Posterior Reversible Encephalopathy Syndrome After Self-Medication With an Oral Decongestant: A Case Report |
title_fullStr | Posterior Reversible Encephalopathy Syndrome After Self-Medication With an Oral Decongestant: A Case Report |
title_full_unstemmed | Posterior Reversible Encephalopathy Syndrome After Self-Medication With an Oral Decongestant: A Case Report |
title_short | Posterior Reversible Encephalopathy Syndrome After Self-Medication With an Oral Decongestant: A Case Report |
title_sort | posterior reversible encephalopathy syndrome after self-medication with an oral decongestant: a case report |
topic | Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935013/ https://www.ncbi.nlm.nih.gov/pubmed/35321464 http://dx.doi.org/10.3389/fmed.2022.837324 |
work_keys_str_mv | AT zerbibyoann posteriorreversibleencephalopathysyndromeafterselfmedicationwithanoraldecongestantacasereport AT gibertlouis posteriorreversibleencephalopathysyndromeafterselfmedicationwithanoraldecongestantacasereport AT bennisyoussef posteriorreversibleencephalopathysyndromeafterselfmedicationwithanoraldecongestantacasereport AT masmoudikamel posteriorreversibleencephalopathysyndromeafterselfmedicationwithanoraldecongestantacasereport AT maizeljulien posteriorreversibleencephalopathysyndromeafterselfmedicationwithanoraldecongestantacasereport AT braultclement posteriorreversibleencephalopathysyndromeafterselfmedicationwithanoraldecongestantacasereport |